Introduction of CELDAZ 500MG INJECTION:

CELDAZ 500MG INJECTION contains
Dacarbazine which belongs to the group of medicines called Anticancer Agents.
It is used to manage certain types of skin cancer (such as metastatic melanoma)
and lymph cancer (such as Hodgkin’s disease). It can also be used in the
management of soft tissue sarcoma (cancer of connective tissues).

Before receiving CELDAZ 500MG INJECTION inform your doctor if you
have any liver or kidney problems. You must also inform your doctor if you have
low WBC and platelet counts in blood or currently receiving radiotherapy as a
precaution. Avoid consumption of alcohol while undergoing therapy with this
medicine.

CELDAZ 500MG INJECTION is not recommended for use in pregnant or
breastfeeding women. Both men and women of childbearing potential must use a
suitable contraceptive to avoid pregnancy while undergoing therapy with this
medicine and until 6 months after the last dose.

The common side effects associated with the use of CELDAZ 500MG
INJECTION are nausea, vomiting, flu-like symptoms, nerve damage and low RBC,
WBC and platelet counts causing tiredness, pale skin, increased infections, fever,
sore throat, chills and increased bleeding or bruising. Consult your doctor if
any of these side effects troubles you.

Uses of CELDAZ 500MG
INJECTION:

• Skin cancer
  (metastatic melanoma)
• Lymph cancer
  (Hodgkin’s disease)
• Soft tissue
  sarcoma (cancer of connective tissues passing between muscles, fat, blood
  vessels and supporting tissues)

How to use CELDAZ 500MG INJECTION:

Your dose and frequency of administration will be decided by
your physician based on your disease condition and other factors. It will be
given to you by a healthcare professional. Do not self-administer.